|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002965,
umls-concept:C0008976,
umls-concept:C0016011,
umls-concept:C0021149,
umls-concept:C0030705,
umls-concept:C0035173,
umls-concept:C0038454,
umls-concept:C0087111,
umls-concept:C0301625,
umls-concept:C0597357,
umls-concept:C0948089,
umls-concept:C0950902,
umls-concept:C1274040,
umls-concept:C1416485
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
1999-5-26
|
|
pubmed:abstractText |
The incidence of stroke in patients with acute coronary syndromes has not been clearly defined because few trials in this patient population have been large enough to provide stable estimates of stroke rates.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:AlbertsM JMJ,
pubmed-author:BerdanL GLG,
pubmed-author:CaliffR MRM,
pubmed-author:DeckersJJ,
pubmed-author:GraffagninoCC,
pubmed-author:GrangerC BCB,
pubmed-author:HarringtonR ARA,
pubmed-author:LaskowitzD TDT,
pubmed-author:LincoffA MAM,
pubmed-author:MacAulayC MCM,
pubmed-author:MahaffeyK WKW,
pubmed-author:MillerJ MJM,
pubmed-author:SimoonsM LML,
pubmed-author:SloanM AMA,
pubmed-author:TopolE JEJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
11
|
|
pubmed:volume |
99
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2371-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10318656-Acute Disease,
pubmed-meshheading:10318656-Age Factors,
pubmed-meshheading:10318656-Aged,
pubmed-meshheading:10318656-Angina, Unstable,
pubmed-meshheading:10318656-Aspirin,
pubmed-meshheading:10318656-Brain Damage, Chronic,
pubmed-meshheading:10318656-Cerebral Hemorrhage,
pubmed-meshheading:10318656-Cerebral Infarction,
pubmed-meshheading:10318656-Cerebrovascular Disorders,
pubmed-meshheading:10318656-Comorbidity,
pubmed-meshheading:10318656-Diabetes Mellitus,
pubmed-meshheading:10318656-Double-Blind Method,
pubmed-meshheading:10318656-Drug Therapy, Combination,
pubmed-meshheading:10318656-Electrocardiography,
pubmed-meshheading:10318656-Female,
pubmed-meshheading:10318656-Heart Rate,
pubmed-meshheading:10318656-Heparin,
pubmed-meshheading:10318656-Humans,
pubmed-meshheading:10318656-Hyperlipidemias,
pubmed-meshheading:10318656-Hypertension,
pubmed-meshheading:10318656-Incidence,
pubmed-meshheading:10318656-Male,
pubmed-meshheading:10318656-Middle Aged,
pubmed-meshheading:10318656-Obesity,
pubmed-meshheading:10318656-Odds Ratio,
pubmed-meshheading:10318656-Peptides,
pubmed-meshheading:10318656-Platelet Aggregation Inhibitors,
pubmed-meshheading:10318656-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:10318656-Prospective Studies,
pubmed-meshheading:10318656-Recurrence,
pubmed-meshheading:10318656-Risk Factors,
pubmed-meshheading:10318656-Smoking,
pubmed-meshheading:10318656-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
|
|
pubmed:affiliation |
Duke Clinical Research Institute, Durham, NC, USA. mahaf002@mc.duke.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
